1887

Abstract

SUMMARY

The ability of serotype 2 outer membrane protein (SP-2) of strain M986 serogroup B, serotype 2a (B, 2a) to stimulate antibody formation in hens and to confer protection against meningococcal challenge to embryos from immunised hens was investigated. Hens, housed with roosters, were immunised with 100 μg of SP-2 once a week for 5 weeks to maintain consistent levels of serum antibody during the study. Antibodies in sera of hens, yolks and plasma of 13-day-old embryos reacted in enzyme-linked immunosorbent assays and immunodiffusion with outer membrane vesicles (OMV) from serotypes 2a, 2b and 2c and most of the other prototype group B strains of . Cross-reactivity of hen sera with most OMV appeared after only one injection of SP-2. Embryos from immunised hens were protected against challenge with up to 10,000 LD50 doses of either the homologous strain M986 (B, 2a) or strain M1011 (B, 2a). Protection was also evident against strains 614 (W135, 2a), S5896 (Y, 2c) and 2241 (C, 2a), but not against strain 78704 (C, 2a) despite strong cross-reactivity of antibody with OMV of this strain. Embryos were only partially protected against strain 78069 (B, 2b) and were fully susceptible to strain 2996 (B, 2b). Some protection was also obtained against meningococcal strains M1080 (B, 1), M982 (B, 9), S3032 (B, 12), 79001 (B, 12), 79694 (B, 15-related) but not strain 77252 (B, nontyp-able). These results suggest that proteins extracted from both serotype 2a and 2b meningococci would provide the broadest protection against infection with group B, serotype 2 meningococci and that antibody, presumably directed against common peptides in the major outer membrane proteins, can prevent infection by some other disease-associated serotypes of .

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-16-4-443
1983-11-01
2024-05-01
Loading full text...

Full text loading...

/deliver/fulltext/jmm/16/4/medmicro-16-4-443.html?itemId=/content/journal/jmm/10.1099/00222615-16-4-443&mimeType=html&fmt=ahah

References

  1. Ashton F. E., Ryan A., Diena B. B. 1980; Improved antiserum agar method for the serogroup differentiation of Neisseria meningitidis Y and W135. Canadian Journal of Microbiology 26:630–632
    [Google Scholar]
  2. Ashton F. E., Ryan A., Diena B. B., Frasch C. E. 1979; Evaluation of the antiserum agar method for the serogroup identification of Neisseria meningitidis. Canadian Journal of Microbiology 25:784–787
    [Google Scholar]
  3. Ashton F. E., Ryan A., Diena B. B., Mackenzie A. M. R., Chan F. 1980; Serotypes among Neisseria meningitidis serogroups B and C strains isolated in Canada. Canadian Journal of Microbiology 26:1480–1488
    [Google Scholar]
  4. Benedict A. A., Larson C., Nik-Khah H. 1963; Synthesis of chicken antibodies of high and low molecular weight. Science 139:1302–1303
    [Google Scholar]
  5. Bovre K., Holten E., Vik-Mo H., Brondbo A., Bratlid D., Bjark P., Moe P. J. 1977; Neisseria meningitidis infections in northern Norway: an epidemic in 1974–1975 due mainly to group B organisms. Journal of Infectious Diseases 135:669–672
    [Google Scholar]
  6. Broud D. D., Griffiss J. M., Baker C. J. 1979; Heterogeneity of serotypes of Neisseria meningitidis that cause endemic disease. Journal of Infectious Diseases 140:465–470
    [Google Scholar]
  7. Buddingh G. J., Polk A. D. 1939; Experimental meningococcus infection of the chick embryo. Journal of Experimental Medicine 70:485–498
    [Google Scholar]
  8. Buxton A. 1952; On the transference of bacterial antibodies from the hen to the chick. Journal of General Microbiology 7:268–286
    [Google Scholar]
  9. Craven D. E., Frasch C. E. 1979; Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model. Infection and Immunity 26:110–117
    [Google Scholar]
  10. Craven D. E., Frasch C. E., Robbins J. R., Feldman H. A. 1978; Serogroup identification of Neisseria meningitidis: comparison of an antiserum agar method with bacterial slide agglutination. Journal of Clinical Microbiology 7:410–414
    [Google Scholar]
  11. DeMaeyer S., Seba J. S.-M., Reginster G. 1981; Epidemiology of meningococcal meningitis in Belgium. Journal of Infection 3(Suppl.) 63–70
    [Google Scholar]
  12. Diena B. B., Ashton F. E., Ryan A., Wallace R., Perry M. B. 1978a; Immunizing properties of gonococcal (R-type) lipopolysaccharide in the chicken embryo animal model. In Immunobiology of Neisseria gonorrhoeae edited by Brooks G. F. American Society for Microbiology; Washington, DC: pp 319
    [Google Scholar]
  13. Diena B. B., Ashton F. E., Ryan A., Wallace R., Perry M. B. 1978b; The lipopolysaccharide (R-type) as a common antigen of Neisseria gonorrhoeae. I. Immunizing properties. Canadian Journal of Microbiology 24:117–123
    [Google Scholar]
  14. Diena B. B., Lavergne G., Ryan A., Ashton F. E., Wallace R. 1976; Transmission of immunity to Neisseria gonorrhoeae from vaccinated hens to embryos. Immunological Communications 5:69–73
    [Google Scholar]
  15. Farries J. S., Dickson W., Greenwood E., Malhotra T. R., Abbott J. D., Jones D. M. 1975; Meningococcal infections in Bolton 1971–1974. Lancet 2:118–120
    [Google Scholar]
  16. Frasch C. E. 1977; Role of protein serotype antigens in protection against disease due to Neisseria meningitidis. Journal of Infectious Diseases 136: Suppl 584–590
    [Google Scholar]
  17. Frasch C. E. 1979; Noncapsular surface antigens of Neisseria meningitidis. In Seminars in infectious disease vol. 2 edited by Weinstein L., Fields. Stratton, New York: pp 304–337
    [Google Scholar]
  18. Frasch C. E., Chapman S. S. 1972a; Classification of Neisseria meningitidis group B into distinct serotypes. Ⅰ. Serological typing by a microbactericidal method. Infection and Immunity 5:98–102
    [Google Scholar]
  19. Frasch C. E., Chapman S. S. 1972b; Classification of Neisseria meningitidis group B into distinct serotypes. Ⅱ. Extraction of type-specific antigens for serotyping by precipitin techniques. Infection and Immunity 6:127–133
    [Google Scholar]
  20. Frasch C. E., Chapman S. S. 1973; Classification of Neisseria meningitidis group B into distinct serotypes. Ⅲ. Application of a new bactericidal-inhibition technique to distribution of serotypes among cases and carriers. Journal of Infectious Diseases 127:149–154
    [Google Scholar]
  21. Frasch C. E., Friedman G. L. 1977; Identification d’un serotype meningococcique associe a la maladie et commun aux meningocoques des groups B, C, YetW135. Medecine Tropicale 37:155–159
    [Google Scholar]
  22. Frasch C. E., Gotschlich E. C. 1974; An outer membrane protein of Neisseria meningitidis group B responsible for serotype specificity. Journal of Experimental Medicine 140:87–104
    [Google Scholar]
  23. Frasch C. E., Peppler M. S. 1982; Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens. Infection and Immunity 37:271–280
    [Google Scholar]
  24. Frasch C. E., Peppler M. S., Cate T. R., Zahradnick J. M. 1982; Immunogenicity and clinical evaluation of group B Neisseria meningitidis outer membrane protein vaccines. In Seminars in infectious disease edited by Robbins J. B., Hill J. C., Sadoff J. Thieme-Stratton; New York: pp 263–267
    [Google Scholar]
  25. Frasch C. E., Robbins J. D. 1978; Protection against group B meningococcal disease. Ⅲ. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. Journal of Experimental Medicine 147:629–644
    [Google Scholar]
  26. Gold R., Winkelhake J. L., Mars R. S., Artenstein M. S. 1971; Identification of an epidemic strain of group C Neisseria meningitidis by bactericidal serotyping. Journal of Infectious Diseases 124:593–597
    [Google Scholar]
  27. Heller E. D. 1975; The immune response of hens to multiple Escherichia coli injections and transfer of immunoglobulins to the egg and hatched chick. Research in Veterinary Science 18:117–597
    [Google Scholar]
  28. Holten E. 1979; Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978. Journal of Clinical Microbiology 9:186–188
    [Google Scholar]
  29. Huet M., Suire A. 1981; Un modéle animal pour l’activite des vaccins polyosidiques meningococciques. Journal of Biological Standardization 9:67–74
    [Google Scholar]
  30. Jones D. M., Eldridge J. 1981; Meningococcal disease in England and Wales. 1978–79—a change in the serotype pattern. Journal of Infection 3:134–139
    [Google Scholar]
  31. Jones D. M., Tobin B. M. 1976; Serotypes of group B meningococci. Journal of Clinical Pathology 29:746–748
    [Google Scholar]
  32. Karthigasu K., Reade P. C., Jenkin C. R. 1965; The functional development of the reticulo-endothelial system. III. The bactericidal capacity of fixed macrophages of foetal and neonatal chicks and rats. Immunology 9:67–73
    [Google Scholar]
  33. Kellogg D. S., Peacock W. L., Deacon W. E., Brown L., Pirkle C. L. 1963; Neisseria gonorrhoeae. I. Virulence genetically linked to clonal variation. Journal of Bacteriology 85:1274–1279
    [Google Scholar]
  34. Kramer T. T., Cho H. C. 1970; Transfer of immunoglobulins and antibodies in the hen’s egg. Immunology 19:157–167
    [Google Scholar]
  35. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
  36. Malkinson M. 1965; The transmission of passive immunity to Escherichia coli from mother to young in the domestic fowl (Gallus domesticus). Immunology 9:311–317
    [Google Scholar]
  37. Munford R. S., Patton C. M., Gorman G. W. 1975; Epidemiologic studies of serotype antigens common to groups B and C Neisseria meningitidis. Journal of Infectious Diseases 131:286–290
    [Google Scholar]
  38. Munoz J. 1971; Double diffusion in plates. In Methods in immunology and immunochemistry vol Ⅲ, edited by Williams C. A., Chase M. W. Academic Press; New York: pp 146–159
    [Google Scholar]
  39. Peppler M. S., Frasch C. E. 1982; Protection against group B Neisseria meningitidis disease: effect of serogroup B polysaccharide and polymyxin B on immunogenicity of serotype protein preparations. Infection and Immunity 37:264–270
    [Google Scholar]
  40. Poolman J. T., Hopman C. T. P., Zanen H. C. 1980; Immunochemical characterization of Neisseria meningitidis serotype antigens by immunodiffusion and SDS-polyacrylamide gel electrophoresis immunoperoxidase techniques and the distribution of serotypes among cases and carriers. Journal of General Microbiology 116:465–473
    [Google Scholar]
  41. The Meningococcal Disease Surveillance Group 1976; Analysis of endemic meningococcal disease by serogroup and evaluation of chemoprophylaxis. Journal of Infectious Diseases 134:201–204
    [Google Scholar]
  42. Tsai C.-M., Frasch C. E. 1980; Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11. Journal of Bacteriology 141:169–176
    [Google Scholar]
  43. Tsai C.-M., Frasch C. E., Mocca L. F. 1981; Five structural classes of major outer membrane proteins in Neisseria meningitidis. Journal of Bacteriology 146:69–78
    [Google Scholar]
  44. Ueda K., Diena B. B., Greenberg L. 1969; The chick embryo neutralization test in the assay of meningococcal antibody. I. Infection of the embryo with Neisseria meningitidis. Bulletin of the World Health Organization 40:235–240
    [Google Scholar]
  45. Varughese P., Acres S. 1980; Meningococcal disease in Canada 1921–1979. Canada Diseases Weekly Report 6:243
    [Google Scholar]
  46. Wallace R., Ashton F. E., Ryan A., Diena B. B., Malysheff C., Perry M. B. 1978; The lipopolysaccharide (R-type) as a common antigen of Neisseria gonorrhoeae. Ⅱ. Use of hen antiserum to gonococcal lipopolysaccharide in a rapid slide test for the identification of N. gonorrhoeae from primary isolates and secondary cultures. Canadian Journal of Microbiology 24:124–128
    [Google Scholar]
  47. Wyle F. A., Artenstein M. S., Brandt B. L., Tramont E. C., Kasper D. L., Altieri P. L., Berman S. L., Lowenthal J. P. 1972; Immunologic response of man to group B meningococcal polysaccharide vaccines. Journal of Infectious Diseases 126:514–522
    [Google Scholar]
  48. Zollinger W. D., Mandrell R. E. 1977; Outer membrane proteins and lipopolysaccharide serotyping of Neisseria meningitidis by inhibition of a solid-phase radioimmunoassay. Infection and Immunity 18:424–433
    [Google Scholar]
  49. Zollinger W. D., Mandrell R. E., Altieri P., Berman S., Lowenthal J., Artenstein M. S. 1978; Safety and immunogenicity of a Neisseria meningitidis type 2 protein vaccine in animals and humans. Journal of Infectious Diseases 137:728–739
    [Google Scholar]
  50. Zollinger W. D., Mandrell R. E., Griffiss J. M., Altieri P., Berman S. 1979; Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man. Journal of Clinical Investigation 63:836–848
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-16-4-443
Loading
/content/journal/jmm/10.1099/00222615-16-4-443
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error